An interventional study of Prediction error tasks in Anorexia Nervosa, sponsored by University of California, San Diego. Active, not recruiting at 1 site in United States. Open to female participants aged 11 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-03.
Sponsored by University of California, San Diego · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Anorexia Nervosa by University of California, San Diego — 5 open to participants now, 7 under way, none of them phase 3. Anorexia Nervosa · University of California, San Diego.
Among the 19 studies in Anorexia Nervosa by University of California, San Diego, this one is the 5th largest by enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2021, is one of 11 with no phase, and was the 9th registered.
471 studies on the registry are indexed under Anorexia Nervosa; 127 are open to participants now.
Browse Anorexia Nervosa studies →5 of the 19 studies in Anorexia Nervosa by University of California, San Diego are open now, in 2 countries. Recruiting first, the newest first:
University of California, San Diego · Sites in United States
Ages 18–45 · Healthy volunteers
University of California, San Diego · Sites in United States
Ages 18–39 · Women only · Healthy volunteers
University of California, San Diego · Sites in United States
Ages 18–45
University of California, San Diego · Sites in United States
Ages 18–39 · Women only · Healthy volunteers
University of California, San Diego · Sites in United States, Canada
Ages 18–55 · Women only · Healthy volunteers
By country, each count listing its studies:
Of the 82 Anorexia Nervosa studies recruiting now, 18 (22%) set no upper age limit and 60 (73%) stop at 75 or younger; 48 take children under 18; 26 take healthy volunteers.
This study: 11 Years to 17 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 47 is close to the median of 46 across 314 interventional studies indexed under Anorexia Nervosa.
Median enrollment 35 across the 14 interventional studies, 78 across the 5 observational. Of the 11 that completed or were terminated, 2 (18%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of California, San Diego is the lead sponsor of 980 studies on the registry; 194 are open to participants now.
Of its 113 completed or terminated interventional studies of FDA-regulated products, 71 (63%) have results posted.
4 of the studies in Anorexia Nervosa by University of California, San Diego that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04583774University of California, San DiegoDeveloping an EEG Paradigm to Study Prediction Error in Anorexia Nervosa | 2026-12 |
| NCT05056597University of California, San DiegoIncentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa | 2027-01 |
| NCT06000774University of California, San DiegoTherapeutic Ketogenic Diet in Anorexia Nervosa | 2027-06 |
| NCT03100656University of California, San DiegoStudy of Food Aversion in Patients With Anorexia Nervosa | 2027-06-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 19 studies in Anorexia Nervosa by University of California, San Diego, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Adolescent anorexia nervosa (AN) is an eating disorder associated with intense fear of weight gain, food refusal, and severe weight loss. AN is the third most common chronic illness among adolescent females with a mortality rate 12 times higher than expected for females 15-24 years old. Little is known about biomarkers in adolescent AN.
Neuroimaging studies have repeatedly suggested altered reward processing in AN including in studies using the dopamine associated prediction error (PE) model. The brain PE response is elicited during unexpected receipt or omission of reward stimuli and thought to reflect the functionality of brain dopamine circuits. This is an important research direction as the dopamine system can be manipulated pharmacologically. In ill and recovered adult AN, unexpected or randomly applied sucrose taste stimuli evoked higher insular and striatal responses and unexpected omission or receipt of monetary or taste reward was associated with a similar response pattern in adolescent AN. PE was also inversely related to weight gain in treatment. Thus, PE brain response promises to be an important biological marker for adolescent AN with predictive value for treatment outcome. However, functional brain imaging is costly, prohibitive for instance for individuals with braces or other metal in their body and only available at certain centers. In order to study PE in AN in larger scale studies, a more practical approach and method need to be developed. In this application, we will use the exploratory/developmental R21 mechanism to develop a study protocol using electroencephalography (EEG) to study PE signals in adolescent AN. Recent studies in healthy individuals support that this is a valid approach.
Our primary goal for this study is to test the feasibility of the use of EEG for prediction error and reversal learning studies in AN with the longer term goal of replacing fMRI that is costly and associated with frequent participant rule out.
In Aim 1. we test the feasibility of adapting a computational taste PE reinforcement learning paradigm from fMRI to EEG in adolescents with AN and healthy controls. We expect that we will find internal consistency of taste PE brain response across fMRI and EEG in adolescents with AN as well as age-matched healthy controls, within each group. We further expect that we will find preliminary evidence that the EEG paradigm will be able to discriminate the AN group from the HC adolescents based on feedback related negativity and higher event-related potential amplitudes, which will correlate with fMRI PE brain response.
In Aim 2., we test whether a monetary PE paradigm will show similar EEG brain response as taste PE in Aim 1. to establish the generalizability of EEG taste and non-taste paradigms.
The development of an EEG based reward PE study paradigm will enable us in the future to conduct large-scale studies that will be less costly and independent from brain imaging centers that are only available to a small subset of adolescents with AN.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Healthy Controls
Restricting Type Anorexia Nervosa
Exclusion Criteria:
Healthy Controls
Major Medical illness (as determined through medical history in bioscreen and PI interview) such as:
Conditions that are life threatening:
Conditions that are life threatening Conditions that cause serious disability without necessarily being life threatening:
Conditions that cause significant pain or discomfort that can cause serious interruptions to life activities:
Conditions that require major commitments of time and effort from care-givers for a substantial period of time:
Conditions that may require frequent monitoring:
Conditions that predict or are associated with severe consequences:
Anorexia Nervosa
Major Medical illness (as determined through medical history in bioscreen and PI interview) such as:
Conditions that are life threatening:
Conditions that are life threatening Conditions that cause serious disability without necessarily being life threatening:
Conditions that cause significant pain or discomfort that can cause serious interruptions to life activities:
Conditions that require major commitments of time and effort from care-givers for a substantial period of time:
Conditions that may require frequent monitoring:
Conditions that predict or are associated with severe consequences:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants with anorexia nervosa
Other: Prediction error tasks
Participants who are considered to be healthy controls
Other: Prediction error tasks
The intervention involves two tasks, one that involves taste stimuli and another that involves monetary stimuli, and test their impact o brain response in electro encephalography (EEG) and functional magnetic resonance imaging (fMRI)
Correlation between Reward Prediction Error Brain Response using functional Magnetic Resonance Imaging (fMRI) and Electroencephalography (EEG)
Study participants will undergo an fMRI session during which they perform a taste reward prediction error paradigm. Blood oxygen-level dependent (BOLD) functional activity will be acquired during the task. The prediction error signal will be modeled based on trial sequence. The same individuals will perform the prediction error task during EEG. fMRI and EEG results for brain regions will be compared and tested for correlations between modalities.
Time frame: Immediate during brain scanning
Reward Prediction Error Brain Response using Electroencephalography (EEG) to separate healthy controls from individuals with anorexia nervosa.
We will test whether regional brain EEG recordings from the taste prediction error paradigm in Outcome 1 can distinguish individuals with anorexia nervosa from healthy controls.
Time frame: Immediate during brain scanning
Monetary Reward Prediction Error Brain Response using EEG will show similar regional brain response compared to taste prediction error response.
Study participants will undergo an EEG session during which they perform a monetary reward prediction error paradigm. The results will be compared to the taste paradigm results from Outcome 1.
Time frame: Immediate during brain scanning
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — No plan to share IPD
Started Feb 2021 (actual). Primary completion is estimated for Dec 2026, 70 months after the start.
Of 149 non-industry interventional studies with no phase under Anorexia Nervosa, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 63. This study's planned 70 months is above that.
Counting every sponsor, half of 149 studies reached it within 43 months; a quarter within 24 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Diego →